Adagene Inc. ADAG
- muzastotug — Colorectal Cancer Phase 2
- muzastotug — Hepatocellular Carcinoma Phase 1
- ADG116 — Solid Tumors Phase 1
- muzastotug — Solid Tumors Phase 1
CTLA-4 (5 companies · 10 programs)
Companies with an active program directed at CTLA-4.
Replimune Group, Inc. REPL
- sturlimgene erparepvec — Uveal Melanoma Phase 2
- sturlimgene erparepvec — Hepatocellular Carcinoma Phase 2
- sturlimgene erparepvec — Biliary Tract Cancer Phase 2
BriaCell Therapeutics Corp. BCTX
- Soluble CD80 Preclinical
Coya Therapeutics, Inc. COYA
- COYA 302 — Frontotemporal Dementia Phase 1
Zenas BioPharma, Inc. ZBIO
- ZB004